Cargando…

In vitro Antimicrobial Activity of Fosfomycin, Rifampin, Vancomycin, Daptomycin Alone and in Combination Against Vancomycin-Resistant Enterococci

PURPOSE: The emergence of vancomycin resistant Enterococci (VRE) is shortening the choices for clinical anti-infective therapy. The aim of this study was to investigate the mechanism of vancomycin resistance and evaluate the effect of fosfomycin (FM), rifampin (RIF), vancomycin (VAN), linezolid (LNZ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tong, Jiepeng, Jiang, Yiheng, Xu, Hao, Jin, Xuehang, Zhang, Li, Ying, Shuaibing, Yu, Wei, Qiu, Yunqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285921/ https://www.ncbi.nlm.nih.gov/pubmed/34285472 http://dx.doi.org/10.2147/DDDT.S315061

Ejemplares similares

In Vitro Antimicrobial Activity of Fosfomycin, Vancomycin and Daptomycin Alone, and in Combination, Against Linezolid-Resistant Enterococcus faecalis
por: Yu, Wei, et al.
Publicado: (2020)

In vitro efficacy of vancomycin combined with fosfomycin against Vancomycin-Resistant Enterococci strains
por: Aktas, Gulseren
Publicado: (2020)

Highly Synergistic Effects of Melittin With Vancomycin and Rifampin Against Vancomycin and Rifampin Resistant Staphylococcus epidermidis
por: Mirzaei, Rasoul, et al.
Publicado: (2022)

Vancomycin-Lipopeptide Conjugates with High Antimicrobial Activity on Vancomycin-Resistant Enterococci
por: Mühlberg, Eric, et al.
Publicado: (2020)

1539. Dalbavancin, Vancomycin, and Daptomycin Alone and in Combination with Cefazolin Against Vancomycin Intermediate-Resistant (VISA) and Daptomycin Non-Susceptible (DNS) Staphylococcus aureus
por: Abdul-Mutakabbir, Jacinda, et al.
Publicado: (2019)

Vancomycin-resistant enterococci: eradication using vancomycin?
por: Van Prehn, J, et al.
Publicado: (2014)

The Combination of Daptomycin with Fosfomycin is More Effective than Daptomycin Alone in Reducing Mortality of Vancomycin-Resistant Enterococcal Bloodstream Infections: A Retrospective, Comparative Cohort Study
por: Tseng, Tai-Chung, et al.
Publicado: (2023)

Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005)
por: Sader, Helio S, et al.
Publicado: (2007)

322 Vancomycin-resistant Enterococci with Reduced Daptomycin Susceptibility in Singapore: Prevalence and Associated Factor
por: Chow, Angela, et al.
Publicado: (2014)

Factorial design and post-antibiotic sub-MIC effects of linezolid combined with fosfomycin against vancomycin-resistant enterococci
por: Yan, Yisong, et al.
Publicado: (2022)

Eradication of Vancomycin-Resistant Enterococci by Combining Phage and Vancomycin
por: Shlezinger, Mor, et al.
Publicado: (2019)

Optimizing the Dosing Regimens of Daptomycin Based on the Susceptible Dose-Dependent Breakpoint against Vancomycin-Resistant Enterococci Infection
por: Santimaleeworagun, Wichai, et al.
Publicado: (2019)

Pharmacodynamics Of Linezolid-Plus-Fosfomycin Against Vancomycin-Susceptible And -Resistant Enterococci In Vitro And In Vivo Of A Galleria mellonella Larval Infection Model
por: Qi, Caifen, et al.
Publicado: (2019)

Evaluation of High-Dose Daptomycin Versus Vancomycin Alone or Combined with Clarithromycin or Rifampin Against Staphylococcus aureus and S. epidermidis in a Novel In Vitro PK/PD Model of Bacterial Biofilm
por: Hall Snyder, Ashley D., et al.
Publicado: (2014)

Emergence of vancomycin-resistant enterococci.
por: Rice, L B
Publicado: (2001)

Risk of vancomycin-resistant enterococci bloodstream infection among patients colonized with vancomycin-resistant enterococci
por: Kara, Ahu, et al.
Publicado: (2014)

In vitro activity of daptomycin & linezolid against methicillin resistant Staphylococcus aureus & vancomycin resistant enterococci isolated from hospitalized cases in Central India
por: Chitnis, Sheetal, et al.
Publicado: (2013)

Antimicrobial susceptibility pattern of vancomycin resistant enterococci to newer antimicrobial agents
por: Gupta, Varsha, et al.
Publicado: (2015)

Molecular Characterization of Virulence Genes in Vancomycin-Resistant and Vancomycin-Sensitive Enterococci
por: Biswas, Priyanka Paul, et al.
Publicado: (2016)

Nosocomial Infection with Vancomycin-dependent Enterococci
por: Tambyah, Paul A., et al.
Publicado: (2004)

Vancomycin-resistant Enterococci, Mexico City
por: Cuellar-Rodríguez, Jennifer, et al.
Publicado: (2007)

Editorial Commentary: Linezolid vs Daptomycin for Vancomycin-Resistant Enterococci: The Evidence Gap Between Trials and Clinical Experience
por: McKinnell, James A., et al.
Publicado: (2015)

Monitoring Antimicrobial Use and Resistance: Comparison with a National Benchmark on Reducing Vancomycin Use and Vancomycin-Resistant Enterococci
por: Fridkin, Scott K., et al.
Publicado: (2002)

In Vitro and In Vivo Studies of Oritavancin and Fosfomycin Synergism against Vancomycin-Resistant Enterococcus faecium
por: Lagatolla, Cristina, et al.
Publicado: (2022)

1955. Novel Compound Reverses Vancomycin Resistance in Vancomycin-resistant Enterococci (VRE)
por: Onyedibe, Kenneth, et al.
Publicado: (2019)

Prevalence of Vancomycin-Resistant Enterococci and Antimicrobial Residues in Wastewater and Surface Water
por: Hricová, Kristýna, et al.
Publicado: (2021)

Combined Action of Antibiotics and Bacteriocins against Vancomycin-Resistant Enterococci
por: Bucheli, Jorge Enrique Vazquez, et al.
Publicado: (2022)

In vitro and in vivo activities of the carbonic anhydrase inhibitor, dorzolamide, against vancomycin-resistant enterococci
por: Abutaleb, Nader S., et al.
Publicado: (2021)

Fecal colonization with vancomycin-resistant enterococci in Australia.
por: Padiglione, A A, et al.
Publicado: (2000)

Involving ornithologists in the surveillance of vancomycin-resistant enterococci.
por: Sellin, M, et al.
Publicado: (2000)

Excretion of Vancomycin-Resistant Enterococci by Wild Mammals
por: Mallon, David J. P., et al.
Publicado: (2002)

Experience report on surveillance of vancomycin-resistant enterococci
por: Baraldi, MM, et al.
Publicado: (2011)

Genotyping of Vancomycin Resistant Enterococci in Arak Hospitals
por: Hoseini Zadeh, Adeleh, et al.
Publicado: (2015)

Alternatives to Fight Vancomycin-Resistant Staphylococci and Enterococci
por: Baëtz, Benjamin, et al.
Publicado: (2021)

Identification of Novel Conjugative Plasmids with Multiple Copies of fosB that Confer High-Level Fosfomycin Resistance to Vancomycin-Resistant Enterococci
por: Sun, Lingyan, et al.
Publicado: (2017)

Genomic Insights to Control the Emergence of Vancomycin-Resistant Enterococci
por: Howden, Benjamin P., et al.
Publicado: (2013)

597. Comparison of Vancomycin and Daptomycin Complications and Interventions in Outpatient Parenteral Antimicrobial Therapy
por: Nakrani, Monark, et al.
Publicado: (2020)

Protein-inspired antibiotics active against vancomycin- and daptomycin-resistant bacteria
por: Blaskovich, Mark A. T., et al.
Publicado: (2018)

Vascular Graft Impregnation with Antibiotics: The Influence of High Concentrations of Rifampin, Vancomycin, Daptomycin, and Bacteriophage Endolysin HY-133 on Viability of Vascular Cells
por: Herten, Monika, et al.
Publicado: (2017)

288 Lack of Synergy With Six Blood Isolates of Methicillin-Resistant Staphylococcus aureus (Vancomycin MIC of 2) Tested With Combinations of Vancomycin + Gentamicin, Vancomycin + Rifampin and Vancomycin + Cefazolin.
por: Long, Virginia, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_siq4jaqrvlemo88r3udmtl17a4